Cardiff Oncology Inc. buy quelbe60
Start price
20.02.22
/
50%
€2.52
Target price
20.02.23
-
Performance (%)
-16.67%
End price
05.03.22
€2.10
Summary
This prediction ended on 05.03.22 with a price of €2.10. The prediction for Cardiff Oncology Inc. disappointed with a performance of -16.67%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | 2.205% | 2.205% | -58.899% | -10.160% |
| iShares Core DAX® | 0.271% | 2.504% | 3.327% | 50.436% |
| iShares Nasdaq 100 | 1.884% | 3.490% | 35.658% | 88.226% |
| iShares Nikkei 225® | 3.579% | 8.127% | 56.653% | 65.166% |
| iShares S&P 500 | 0.151% | 1.918% | 24.108% | 64.489% |
Comments by quelbe60 for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.